Written by : Jayati Dubey
April 16, 2025
By integrating AI-driven retinal screening into routine diabetes management, the center aims to improve early diagnosis and ensure timely intervention.
Dr. Mohan’s Diabetes Specialities Centre (DMDSC) has announced the launch of an artificial intelligence-driven software designed to detect early signs of retinal damage, a key complication of diabetes.
The new tool, which offers rapid and highly accurate analysis, enables timely medical intervention to help reduce the risk of vision impairment in patients with diabetes.
The AI-based screening software was initially deployed at DMDSC’s flagship clinics in Puducherry and Thanjavur, regions that were identified for their high prevalence of diabetes. The organization plans to expand the solution to all 50 of its clinics across the country.
“AI is transforming healthcare, and this innovation will help us detect complications early and improve patient outcomes,” said Dr. V. Mohan, Chairman of Dr. Mohan’s Diabetes Specialities Centre.
Diabetic retinopathy, a silent but serious complication, often goes undiagnosed until significant retinal damage has occurred.
By integrating AI-driven retinal screening into routine diabetes management, the center aims to improve early diagnosis and ensure timely intervention.
Dr. R. M. Anjana, Managing Director of DMDSC, highlighted the importance of preventive care.
“With diabetes cases on the rise, it is crucial to integrate eye care into standard diabetes management. This initiative is a game-changer, enabling early detection and significantly reducing the risk of irreversible vision loss.”
The rollout in Puducherry and Thanjavur is part of a broader effort to strengthen local access to high-quality, proactive eye care.
DMDSC aims to ensure patients receive effective screening and treatment closer to home, helping bridge the gap between diagnosis and care in underserved regions.
Stay tuned for more such updates on Digital Health News.